Twist Bioscience Corp vs Vanguard Ultra Short Bond ETF — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Vanguard Ultra Short Bond ETF trades at $49.71. The key difference: Twist Bioscience Corp is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| TWST | VUSB | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $102.88 | $50.03 |
52-Week Low | $24.16 | $49.60 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →